AstraZeneca encounters a surge in shares as profits exceed expectations, buoyed by demand for cancer drugs [Fortune]
AstraZeneca PLC - American Depositary Shares (AZN)
Last astrazeneca plc - american depositary shares earnings: 2/5 04:00 pm
Check Earnings Report
US:NYSE Investor Relations:
astrazeneca.com/investor-relations.html
Company Research
Source: Fortune
Earnings per share excluding some items rose 7% to $2.06 in the first quarter, the UK drugmaker said Thursday. Analysts surveyed by Bloomberg expected $1.89 on average. Astra has been on a deal spree, agreeing to buy Fusion Pharmaceuticals Inc. and Amolyt Pharma in March to beef up the flow of drugs it aims to bring to market. The shares rose as much as 6.5% in early London trading, the most in more than 3 years. Tagrisso and Enhertu, which just won new clearances in the US, and the rare-disease drug Ultomiris, helped revenue rise 17% last quarter. “This was the first quarter that both our biopharma business and our oncology business exceeded $5 billion in revenue,” Chief Financial Officer Aradhana Sarin said in a TV interview. “And our rare-disease business was over $2 billion. It's not one or two medicines driving the growth, it's a very broad base.” The drugmaker will discuss its pipeline — including the timing of future treatments and their revenue potential — at an inves
Show less
Read more
Impact Snapshot
Event Time:
AZN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AZN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AZN alerts
High impacting AstraZeneca PLC - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
AZN
News
- Top Analyst Reports for AstraZeneca, QUALCOMM & FedEx [Yahoo! Finance]Yahoo! Finance
- AstraZeneca reports positive interim data from mantle cell lymphoma trial [Yahoo! Finance]Yahoo! Finance
- Box Sets Date to Announce First Quarter Fiscal 2025 Financial Results [Yahoo! Finance]Yahoo! Finance
- Matan's Lease with AstraZeneca at 700 Progress Way Awarded 'Best Maryland Lease of 2023' by the Washington Business Journal [Yahoo! Finance]Yahoo! Finance
- The World Market for Ovarian Cancer Drugs to 2030: Breakthroughs in Combination Drug Therapy Transforming Standards of Care [Yahoo! Finance]Yahoo! Finance
AZN
Sec Filings
- 5/2/24 - Form 6-K
- 5/1/24 - Form 6-K
- 4/29/24 - Form 6-K
- AZN's page on the SEC website